http://www.neogenomics.com - Use of aspirin in colorectal cancer has previously been associated with favorable outcome. In a current study in the New England Journal of Medicine, Liao et al. report that 5-year cancer-related mortality was reduced by about 80% with regular use of aspirin when patients’ tumors had mutations in the PIK3CA gene. NeoGenomics Laboratories is a specialized cancer diagnostics reference laboratory with four labs in the United States. NeoGenomics BRAF Mutation Analysis in Melanoma provides comprehensive analysis of the critical region of BRAF.